MedTrace Logo

Investigating the Clinical Features and Prognosis of Bronchiectasis Adult Patients

NCT04987827 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1250

Last updated 2021-08-03

No results posted yet for this study

Summary

Bronchiectasis is a chronic respiratory disease characterized by permanent bronchiectasis.The incidence and prevalence of bronchiectasis have assumed continuously grows in global. Different from overseas, bronchiectasis is common disease in China. This study will collect data from the real-world bronchiectasis database and follow up for one year, describe the bronchiectasis exacerbation rate and proportions for frequent exacerbation, clinical features and prognosis of bronchiectasis exacerbation, the treatment pattern (when clinically stable) during follow-up period; and describe characteristics of bronchiectasis at baseline. This study will also explore potential baseline risk factors for bronchiectasis exacerbation during follow-up period.

Conditions

  • Bronchiectasis Adult

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Ruijin Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-04-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04987827 on ClinicalTrials.gov